- Home
- Health
Biden ‘wouldn’t hesitate’ receiving a COVID-19 vaccine, blames Trump for vaccine skepticism
In an ongoing battle against President Donald Trump over a chosen election victor, President-elect Joe Biden said Monday that he “wouldn’t hesitate” on receiving the COVID-19 vaccine if approved by…
By Colby McCoyLatest news
Moderna says its COVID-19 vaccine candidate is 94.5 percent effective
Moderna, Inc. (NASDAQ: MRNA) announced that its COVI-19 vaccine candidate is 94.5% effective in preventing the disease based…
By Marivic Cabural SummersNational lockdown to curb COVID-19 spread ‘last resort’: Biden health adviser
A national lockdown of businesses and schools is a “measure of last resort,” former Surgeon General Dr. Vivek…
By Dee DulfoIndivior Solutions to pay $289M in criminal penalties for illegally marketing Suboxone
A federal court ordered Indivior Solutions to pay $289 million in criminal penalties for unlawfully marketing Suboxone, an…
By Marivic Cabural SummersMeasles cases hit 23-year high in 2019, another spike feared as COVID-19 rages on
Cases of childhood disease measles reached the highest level in 23 years in 2019, the World Health Organization…
By Dee DulfoGates Foundation, EU governments donate millions of dollars to provide COVID-19 vaccines to poor countries
In a bid to develop and deliver COVID-19 vaccines that will be supplied to everyone including those in…
By Dee DulfoModerna days away from releasing key COVID-19 vaccine data
The stock price of Moderna (NASDAQ: MRNA) following news that critical COVID-19 vaccine data from late-stage trials would be…
By Colby McCoy4-to-6 week lockdown could control COVID-19 pandemic, reboot economy: Biden advisor
Closing down businesses and paying people for lost wages during a 4-to-6 week lockdown could get the COVID-19…
By Dee DulfoJustices Roberts, Kavanaugh suggest they won’t strike down Obamacare
Two U.S. Supreme Court justices on the conservative wing expressed skepticism toward arguments that the Affordable Care Act…
By Dee DulfoFDA grants Eli Lilly emergency use authorization for bamlanivimab treatment for COVID-19
The U.S. Food and Drug Administration (FDA) granted Eli Lilly and Company (NYSE: LLY) an emergency use authorization…
By Marivic Cabural SummersBiden convenes COVID-19 task force and celebrates vaccine progress
President-elect Joe Biden convened a COVID-19 task force on Monday, to devise a cohesive framework to tackle the…
By Colby McCoyPopular News
FDA warns public as cookie firm rejects urgent recall request
Trump orders CDC to slash childhood vaccines from 17 to 11
